Senior insider sale
Chief Financial Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$36.6K
7.67K shares
What this filing means
JORGENSEN NATHAN D. plans to sell 7.67K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $36.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/3/2025ACC: 0001959173-25-006343
Officer· Chief Financial Officer
Since Feb 2026
7.67K
Shares to sell
$36.6K
Approx. market value
7.67K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
10/1/2025
7.67KTotal acquired7.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2025 | Restricted Stock Vesting Compensation | 7.67K | — |
| Total | 7.67K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.67K
Market value
$36.6K
10/3/2025
Total
Units
7.67K
Value
$36.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/3/2025 | 7.67K | $36.6K | NASDAQ | Planned |
| Total | 7.67K | $36.6K | ||